Departments of Anesthesiology, Surgery, and Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN.
Departments of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA.
Reg Anesth Pain Med. 2013 Sep-Oct;38(5):409-414. doi: 10.1097/AAP.0b013e31829ecfa6.
Hematoma associated with epidural catheterization is rare, but the diagnosis might be suspected relatively frequently. We sought to estimate the incidence of suspected epidural hematoma after epidural catheterization and to determine the associated cost of excluding or diagnosing an epidural hematoma through radiologic imaging.
We conducted an electronic retrospective chart review of 43,200 patient charts using 4 distinct search strategies and cost analysis, all from a single academic institution from 2001 through 2009. The charts were reviewed for use of radiologic imaging studies to identify patients with suspected and confirmed epidural hematomas. Costs for imaging to exclude or confirm the diagnosis were related to the entire cohort.
In our analysis, during a 9-year period that included 43,200 epidural catheterizations, 102 patients (1/430) underwent further imaging studies to exclude or confirm the presence of an epidural hematoma-revealing 6 confirmed cases and an overall incidence (per 10,000 epidural blocks) of epidural hematoma of 1.38 (95% confidence interval, 0-0.002). Among our patients, 207 imaging studies, primarily lumbar spine magnetic resonance imaging, were performed. Integrating Medicare cost expenditure data, the estimated additional cost during a 9-year period for imaging and hospital charges related to identifying epidural hematomas nets to approximately $232,000 or an additional $5.37 per epidural.
Approximately 1 in 430 patients undergoing epidural catheterization will be suspected to have an epidural hematoma. The cost of excluding the diagnosis, when suspected, is relatively low when allocated across all patients undergoing epidural catheterization.
硬脊膜外腔导管置管相关的血肿较为罕见,但诊断相对较为常见。本研究旨在评估硬脊膜外腔导管置管后疑似硬脊膜外血肿的发生率,并确定通过影像学检查排除或诊断硬脊膜外血肿的相关成本。
我们采用 4 种不同的搜索策略并进行了回顾性电子病历分析,共纳入 43200 例患者,所有患者均来自于 2001 年至 2009 年期间的一家学术机构。通过回顾病历以明确是否使用影像学检查来识别疑似和确诊的硬脊膜外血肿患者。将排除或确诊所需的影像学检查费用与整个队列相关联。
在我们的分析中,在 9 年期间,43200 例硬脊膜外腔导管置管中有 102 例(1/430)患者进行了进一步的影像学检查以排除或确认硬脊膜外血肿的存在——发现 6 例确诊病例,硬脊膜外血肿的总体发生率(每 10000 例硬脊膜外阻滞)为 1.38(95%置信区间,0.002)。在我们的患者中,进行了 207 项影像学检查,主要为腰椎磁共振成像。整合医疗保险费用支出数据,9 年期间因识别硬脊膜外血肿而进行影像学检查和医院收费的估计额外费用约为 232000 美元,或每例硬脊膜外阻滞增加 5.37 美元。
大约每 430 例硬脊膜外腔导管置管患者中就有 1 例会被怀疑患有硬脊膜外血肿。当疑似时,排除诊断的成本相对较低,在所有接受硬脊膜外腔导管置管的患者中进行分配时更是如此。